Hovedbudskap
Det selges helsekost for milliardbeløp årlig i Norge
Kosttilskudd er oftest ikke dokumentert effektive
Ofte er det en snev av sannhet og «frekk» bruk av ny kunnskap i markedsføringen. Lettvinte løsninger lanseres for å løse vanskelige problemer
Ansvarlige myndigheter reagerer ofte sent på slik markedsføring
- 1.
Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295 – 300.
- 2.
Virtamo J, Pietinen P, Huttunen JK, Korhonen P, Malila N, Virtanen MJ et al. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA 2003; 290: 476 – 85.
- 3.
Johansson LRK, Solvoll K, Bjørneboe G-EA, Drevon CA. Intake of very-long chain n-3 fatty acids related to social status and lifestyle. Eur J Clin Nutr 1998; 52: 716 – 21.
- 4.
Rustan AC, Drevon CA. Fatty acids: structures and properties. Encyclopedia of life sciences. London: Nature Publishing, 2000.
- 5.
Kris-Etherton PM, Harris WS, Appel LJ. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol 2003; 23: 151 – 2.
- 6.
Burr ML, Sweetham PM, Fehily AM. Diet and reinfarction. Eur Heart J 1994; 15: 1152 – 3.
- 7.
Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002; 105: 1897 – 903.
- 8.
Calder PC. Dietary modification of inflammation with lipids. Proc Nutr Soc 2002; 61: 345 – 58.
- 9.
Rhodes LE, Shahbakhti H, Azurdia RM, Moison RM, Steenwinkel MJ, Homburg MI et al. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers. Carcinogenesis 2003; 24: 919 – 25.
- 10.
Makrides M, Neumann M, Simmer K, Pater J, Gibson R. Are long-chain polyunsaturated fatty acids essential nutrients in infancy? Lancet 1995; 345: 1463 – 8.
- 11.
Helland IB, Smith L, Saarem K, Saugstad OD, Drevon CA. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics 2003; 111: e39.
- 12.
Johansson L, Solvoll K, Bjørneboe G-EA, Drevon CA. Dietary habits among Norwegian adults. Scand J Nutr 1997; 41: 63 – 70.
- 13.
Meyer HE, Tverdal A, Selmer R. Weight variability, weight change and the incidence of hip fracture: a prospective study of 39,000 middle-aged Norwegians. Osteoporos Int 1998; 8: 373 – 8.
- 14.
Michaelsson K, Lithell H, Vessby B, Melhus H. Serum retinol levels and the risk of fracture. N Engl J Med 2003; 348: 287 – 94.
- 15.
Myhre AM, Carlsen MH, Boehn SK, Wold HL, Laake P, Blomhoff R. Water-miscible, emulsified, and solid forms of retinol supplements are more toxic than oil-based preparations. Am J Clin Nutr 2003; 78: 1152 – 9.
- 16.
Monsen ALB, Ueland PM. Homocysteine and methylmalonic acid in diagnosis and risk assessment from infancy to adolescence. Am J Clin Nutr 2003; 78: 7 – 21.
- 17.
Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 1991; 338: 131 – 7.
- 18.
Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327: 1832 – 5.
- 19.
Rimm EB, Willett WC, Hu FB, Sampson L, Colditz GA, Manson JE et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998; 279: 359 – 64.
- 20.
Pelucchi C, Talamini R, Negri E, Levi F, Conti E, Franceschi S et al. Folate intake and risk of oral and pharyngeal cancer. Ann Oncol 2003; 14: 1677 – 81.
- 21.
Giovannucci E, Chen J, Smith-Warner SA, Rimm EB, Fuchs CS, Palomeque C et al. Methylenetetrahydrofolate reductase, alcohol dehydrogenase, diet, and risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2003; 12: 970 – 9.
- 22.
French AE, Grant R, Weitzman S, Ray JG, Vermeulen MJ, Sung L et al. Folic acid food fortification is associated with a decline in neuroblastoma. Clin Pharmacol Ther 2003; 74: 288 – 94.
- 23.
Van Rooij IA, Swinkels DW, Blom HJ, Merkus HM, Steegers-Theunissen RP. Vitamin and homocysteine status of mothers and infants and the risk of nonsyndromic orofacial clefts. Am J Obstet Gynecol 2003; 189: 1155 – 60.
- 24.
Shaw GM, Zhu H, Lammer EJ, Yang W, Finnell RH. Genetic variation of infant reduced folate carrier (A80G) and risk of orofacial and conotruncal heart defects. Am J Epidemiol 2003; 158: 747 – 52.
- 25.
Feigelson HS, Jonas CR, Robertson AS, McCullough ML, Thun MJ, Calle EE. Alcohol, folate, methionine, and risk of incident breast cancer in the American Cancer Society Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 2003; 12: 161 – 4.
- 26.
Borch-Iohnsen B, Hauge A. Bør jernpreparater reseptbelegges? Tidsskr Nor Lægeforen 2001; 121: 460 – 2.
- 27.
Tuomainen TP, Punnonen K, Nyyssonen K, Salonen JT. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 1998; 97: 1461 – 6.
- 28.
Slavin JL, Jacobs D, Marquart L, Wiemer K. The role of whole grains in disease prevention. J Am Diet Assoc 2001; 101: 780 – 5.
- 29.
Jacobs DR jr., Meyer HE, Solvoll K. Reduced mortality among whole grain bread eaters in men and women in the Norwegian County Study. Eur J Clin Nutr 2001; 55: 137 – 43.
- 30.
Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartiainen E. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med 1995; 333: 1308 – 12.
- 31.
Berge RK, Skorve J, Tronstad KJ, Berge K, Gudbrandsen OA, Grav H. Metabolic effects of thia fatty acids. Curr Opin Lipidol 2002; 13: 295 – 304.
- 32.
Booth SL, Broe KE, Gagnon DR, Tucker KL, Hannan MT, McLean RR et al. Vitamin K intake and bone mineral density in women and men. Am J Clin Nutr 2003; 77: 512 – 6.
- 33.
Allison AC. The possible role of vitamin K deficiency in the pathogenesis of Alzheimer’s disease and in augmenting brain damage associated with cardiovascular disease. Med Hypotheses 2001; 57: 151 – 5.
- 34.
Blusztajn JK. Choline, a vital amine. Science 1998; 281: 794 – 5.